Bayer Must Answer Schering Stockholder Query: Court
The ruling, handed down Wednesday in a German court, was reported by Dow Jones newswire Wednesday.
The shareholders wanted Bayer to answer several questions regarding the takeover, particularly the expectations Bayer had for the multiple sclerosis drug Betaseron and the evaluation Bayer made about possible cost savings and synergies.
The shareholders did not get those questions answered by...
To view the full article, register now.